Expanded Access Case Report of SNIPR001, an Engineered CRISPR Medicine, in Rare Intracellular E. coli Disease Published in Clinical Infectious Diseases
SNIPR today announced the publication of a peer-reviewed expanded access case report in Clinical Infectious Diseases describing the use of SNIPR001 in a kidney transplant recipient with progressive, multidrug-resistant Escherichia coli malakoplakia, a rare disease characterized by intracellular bacterial persistence.